Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Morgensztern

Showing results (61-70 of 184) with videos related to

Pageof 19
Sort By:
Neoplasia (New York, N.Y.)|November 2, 2017
Nothing But NET: A Review of Neuroendocrine Tumors and CarcinomasBryan Oronsky, Patrick C Ma, Daniel Morgensztern, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2008
The effect of FDG-PET on the stage distribution of non-small cell lung cancerDaniel Morgensztern, Boone Goodgame, Maria Q Baggstrom, et al.
Leukemia & Lymphoma|February 2, 2011
Lack of survival improvement in patients with peripheral T-cell lymphoma: a Surveillance, Epidemiology, and End Results analysisDaniel Morgensztern, Gail R Walker, Leonidas G Koniaris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 23, 2012
Targeting vascular endothelial growth factor in patients with squamous cell lung cancerPeter J Koo, Daniel Morgensztern, Julie L Boyer, et al.
Leukemia & Lymphoma|September 14, 2004
Somatostatin receptor scintigraphy in MALT lymphoma of the lacrimal gland treated with rituximabDaniel Morgensztern, Manuel F Rosado, Aldo N Serafini, et al.
Leukemia & Lymphoma|January 14, 2012
Waldenström macroglobulinemia: a Surveillance, Epidemiology, and End Results database review from 1988 to 2005Jeevan Sekhar, Kristen Sanfilippo, Qin Zhang, et al.
American Journal of Hematology|September 25, 2004
Chronic lymphocytic leukemia-associated nephrotic syndrome caused by focal segmental glomerulosclerosisManuel F Rosado, Daniel Morgensztern, Sakher Abdullah, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 18, 2012
Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003Daniel Morgensztern, Saiama Waqar, Janakiraman Subramanian, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 2, 2010
Review of ongoing clinical trials in non-small cell lung cancer: a status report for 2009 from the ClinicalTrials.gov websiteJanakiraman Subramanian, Anusha R Madadi, Monica Dandona, et al.
Seminars in Oncology|May 8, 2026
Risk of intensive care unit admission after immune checkpoint inhibitor use in cancerMaun R Baral, Sambhawana Bhandari, Daniel Morgensztern, et al.
Pageof 19

Showing results (61-70 of 184) with videos related to

Sort By:
Pageof 19
Neoplasia (New York, N.Y.)|November 2, 2017
Nothing But NET: A Review of Neuroendocrine Tumors and CarcinomasBryan Oronsky, Patrick C Ma, Daniel Morgensztern, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2008
The effect of FDG-PET on the stage distribution of non-small cell lung cancerDaniel Morgensztern, Boone Goodgame, Maria Q Baggstrom, et al.
Leukemia & Lymphoma|February 2, 2011
Lack of survival improvement in patients with peripheral T-cell lymphoma: a Surveillance, Epidemiology, and End Results analysisDaniel Morgensztern, Gail R Walker, Leonidas G Koniaris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 23, 2012
Targeting vascular endothelial growth factor in patients with squamous cell lung cancerPeter J Koo, Daniel Morgensztern, Julie L Boyer, et al.
Leukemia & Lymphoma|September 14, 2004
Somatostatin receptor scintigraphy in MALT lymphoma of the lacrimal gland treated with rituximabDaniel Morgensztern, Manuel F Rosado, Aldo N Serafini, et al.
Leukemia & Lymphoma|January 14, 2012
Waldenström macroglobulinemia: a Surveillance, Epidemiology, and End Results database review from 1988 to 2005Jeevan Sekhar, Kristen Sanfilippo, Qin Zhang, et al.
American Journal of Hematology|September 25, 2004
Chronic lymphocytic leukemia-associated nephrotic syndrome caused by focal segmental glomerulosclerosisManuel F Rosado, Daniel Morgensztern, Sakher Abdullah, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 18, 2012
Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003Daniel Morgensztern, Saiama Waqar, Janakiraman Subramanian, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 2, 2010
Review of ongoing clinical trials in non-small cell lung cancer: a status report for 2009 from the ClinicalTrials.gov websiteJanakiraman Subramanian, Anusha R Madadi, Monica Dandona, et al.
Seminars in Oncology|May 8, 2026
Risk of intensive care unit admission after immune checkpoint inhibitor use in cancerMaun R Baral, Sambhawana Bhandari, Daniel Morgensztern, et al.
Pageof 19